• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-09

  Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG used as a primary or assay-linked immunoglobulin in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used for direct antigen detection or with non-goat primary antibodies unless cross-reactivity has been specifically validated.

• Trichostatin A: HDAC Workflows and Optimization

  2026-09-09

  Trichostatin A (TSA) gives researchers a reversible way to probe HDAC-dependent chromatin, differentiation, cell-cycle, and cytoskeletal biology. This practical guide connects cancer assays with a recent HDAC6–tubulin lactylation discovery while emphasizing controls, exposure design, and troubleshooting.

• Nifedipine (BAY-a-1040) Assay Workflows

  2026-09-08

  Nifedipine (BAY-a-1040) provides a controlled way to test how L-type calcium influx shapes cell signaling, contraction, viability, and transport. Its greatest experimental value emerges when calcium perturbation is paired with orthogonal PXR and CYP measurements rather than interpreted as a direct liver-metabolism signal.

• MLN8237: A Mechanistic Mitosis Assay Guide

  2026-09-08

  MLN8237 (Alisertib) is more than a selective Aurora A inhibitor: it can serve as a mechanistic probe for connecting mitotic disruption, aneuploidy, and apoptosis. This guide integrates product pharmacology with a flow-cytometric assay framework to improve experimental design and interpretation.

• NSC 87877: A Practical Shp2 Inhibitor Guide

  2026-09-07

  This scenario-based guide explains how NSC 87877, SKU A4544, can be used to design more interpretable Shp2 signaling, cell viability, proliferation, and cytotoxicity experiments. It covers assay compatibility, concentration selection, formulation controls, evidence translation, and practical product-selection criteria.

• TRAP-1 Reactivates Mutant p53Y220C

  2026-09-07

  The preprint reports TRAP-1, a chemical inducer of proximity that assembles mutant p53Y220C and BRD4 into a ternary complex, restoring transcriptional activity rather than merely stabilizing the mutant protein. In p53Y220C-expressing pancreatic cancer cell lines, this mechanism rapidly increased p21 and other p53 target genes while inhibiting cell growth, although broader validation remains necessary.

• Self-Assembling EVMPs for Extrahepatic mRNA Delivery

  2026-09-05

  This ACS Nano study introduces a bottom-up enveloped virus-mimicking particle (EVMP) assembled from a designed peptide, mRNA, and tissue-selective phospholipids. The platform enabled substantial delivery to lung and spleen, including endothelial and immune cells, while supporting repeated dosing and IL-12 mRNA treatment in a metastatic lung tumor model.

• Polybrene and the Translational Logic of p53 Reactivation

  2026-09-04

  A translational strategy for using Polybrene as a controlled gene-delivery variable when studying mutant p53 biology, including TRAP-1–mediated reactivation of p53Y220C. The article connects charge-mediated viral uptake with assay rigor, reproducibility, and the limits of extrapolating delivery performance into oncology conclusions.

• Cellular Senescence Signatures in Abdominal Aortic Aneurysm

  2026-09-04

  The reference study integrates transcriptomic analysis, cellular senescence gene sets, machine learning, and experimental validation to identify ETS1 and ITPR3 as candidate biomarkers for abdominal aortic aneurysm. Its workflow offers a practical framework for moving from discovery datasets to stage-aware validation while highlighting senescent endothelial cells as a potentially important component of aneurysm biology.

• Computational Hapten Design for Dual-Toxin Biosensing

  2026-09-03

  This 2026 study combines molecular similarity analysis, quantum chemical calculations, and antibody engineering to create a dual-target fluorescent immunochromatographic assay for amatoxins and phallotoxins in mushrooms. Its main contribution is the use of computationally guided hapten selection to improve uniform antibody recognition across chemically related toxins, enabling sensitive simultaneous screening in fresh and dried mushroom samples.

• Bobcat339 for TET Inhibition and DNA Methylation Studies

  2026-09-03

  Bobcat339 is a cytosine structure-based TET enzyme inhibitor for testing how TET1/TET2 activity connects DNA methylation regulation with gene transcription modulation. This guide translates the UHRF1–5-mC–TGM2 findings in senile osteoporosis into practical biochemical, cellular, and multi-omics workflows while emphasizing controls, dose optimization, and interpretation limits.

• Budesonide in Reliable Cell Assays

  2026-09-02

  Learn how Budesonide (SKU B1900) can be integrated into cell viability, proliferation, and airway inflammation workflows with solvent controls, exposure planning, and permeability context. The article connects product specifications with practical interpretation for asthma inflammation models and respiratory disease research.

• NADPH Oxidase ROS Drive Arterial Contraction in Rat Pups

  2026-09-02

  The reference study shows that NADPH oxidase-derived reactive oxygen species promote contraction of early postnatal rat saphenous arteries primarily through L-type voltage-gated calcium channels, rather than through Rho-kinase, PKC, or Src kinase. Its inhibitor-interaction design helps distinguish pathways that reduce contraction generally from the pathway specifically required for the ROS-sensitive contractile response.

• Vancomycin Hydrochloride as a Mechanistic Control

  2026-09-01

  Vancomycin hydrochloride is more than a Gram-positive antibacterial standard: it can define assay boundaries when antimicrobial and antibiofilm candidates are tested against difficult organisms. This article translates findings from LL-37 research into a mechanism-aware framework for susceptibility, biofilm, and resistance experiments.

• LL-37 Fragments Against MDR Acinetobacter Biofilms

  2026-09-01

  The reference study shows that human cathelicidin LL-37 and selected truncated fragments can combine rapid antibacterial activity with inhibition and disruption of multidrug-resistant Acinetobacter baumannii biofilms. Its use of MIC, time-kill, adherence, biofilm-eradication, and cytotoxicity assays provides a practical framework for evaluating peptide-based strategies against organisms that are difficult to treat.

8006 records 1/534 page Next 12345 下5页 Last page